Sci Simple

New Science Research Articles Everyday

# Biology # Bioengineering

Understanding Vascular Malformations: A Complex Challenge

Learn about vascular malformations, their causes, and treatment options.

Wen Yih Aw, Aanya Sawhney, Mitesh Rathod, Chloe P. Whitworth, Elizabeth L. Doherty, Ethan Madden, Jingming Lu, Kaden Westphal, Ryan Stack, William J. Polacheck

― 6 min read


Vascular Malformations Vascular Malformations Explained malformations and their complexities. Key insights into vascular
Table of Contents

Vascular malformations (VMs) are unusual growths in blood vessels. They can occur in veins, arteries, capillaries, or lymphatic vessels, making them a bit of a jigsaw puzzle. These malformations are linked to genetic changes and can cause various symptoms based on where they appear in the body.

How Do They Work?

At a microscopic level, these malformations are like construction sites gone wrong. Instead of neat and orderly structures, you have tangled messes of blood vessels with irregular shapes. The cells lining these vessels are not behaving properly and the surrounding support structure is all mixed up. This can lead to problems like blood flow issues and, in some cases, can be quite dangerous.

The Big Trouble with VMs

Many times, these malformations are present from birth and can worsen as someone ages. They can block blood flow or make it hard for the body to drain fluids properly. If not addressed, they can even become life-threatening. The standard fix for these pesky malformations is surgery, sclerotherapy (a fancy word for injecting a solution to get rid of the malformation), or a small list of medications that may or may not help.

What Causes VMs?

The root of the problem lies in somatic Mutations in specific genes that help the blood vessels grow and develop. These genes are also involved in creating new blood vessels when tumors form. VMs are sorted into slow-flow or fast-flow based on how blood moves through them.

Most slow-flow types, which don’t have an artery component, are caused by gene mutations that ramp up certain cellular signals, leading to abnormal growth. For instance, a mutation in a gene called PIK3CA is found in about 80% of cases involving certain fluid-filled growths called cystic lymphatic malformations.

The Role of Signals

When blood flow is normal, Endothelial Cells (the cells lining the blood vessels) will stretch and align in the direction of the flow. However, mutations in the PIK3CA gene can disrupt these normal responses. This means the blood vessels cannot adapt to the forces of flowing blood, leading to more issues.

What Do These Cells Do?

Normally, phosphatidylinositol-3-kinases (PI3K) play an essential role in helping cells grow, move, and survive. When signaling goes wrong due to mutations, it can lead to problems with the cells that line the blood vessels. They become disorganized and can even grow out of control.

What Happens to Endothelial Cells?

When endothelial cells are exposed to normal blood flow, they stretch and align nicely, making sure everything runs smoothly. But with the PIK3CA mutation, they stay in more of a clumpy state and don’t change shape like they’re supposed to. They also become less effective at forming tight connections with each other which is crucial for keeping the blood vessel walls intact.

How Do We Study These Malformations?

Scientists often use special models to replicate VMs in a lab. By studying how the endothelial cells behave in response to different forces, researchers can better understand the mechanisms behind these malformations. For instance, when exposed to shear stress (the force of blood flow), normal endothelial cells elongate and align, while those with mutations fail to do so.

The Impact of Fluid Flow

Fluid flow is crucial for vascular health. It helps keep blood vessels in shape and functional. In cases of VMs, the endothelial cells do not respond properly to this flow, leading to instability in the junctions between cells. This can increase permeability, making it easier for fluids to leak out from the vessels, which is like having a leaky garden hose—definitely not ideal!

The Influence of the Microenvironment

The surrounding environment, including the structure and fluid dynamics, can influence how blood vessels develop. The soft and flexible tissues where VMs often occur affect the behavior of endothelial cells. This can lead to further issues, such as dilated blood vessels that sprout incorrectly.

When Things Go Awry: Observing Cell Behavior

In studies, researchers have found that endothelial cells with the PIK3CA mutation are larger and more rounded compared to normal cells. These mutated cells are less organized and do not form tight connections with neighboring cells, leading to a higher risk of leakage in the blood vessels.

What Can Be Done?

To tackle VMs, there is no one-size-fits-all solution. Treatment options can vary greatly depending on the complexity and location of the malformation. Some may require surgery or other interventions, while others might need monitoring.

The Physical Forces at Play

Fluid dynamics don’t just affect how blood moves, they also impact how blood vessels form and behave. When blood vessels don’t respond to these forces correctly, it can lead to complications. For instance, endothelial cells with PIK3CA mutations are often unable to stretch in response to the flow, contributing to their abnormal growth.

The Mysterious Role of Pressure

When examining VMs, scientists found that varying pressure and fluid flow can encourage the mutated cells to misbehave further. This bypassing of normal responses can cause the growth of abnormal blood vessels and the sprouting of new, unnecessary pathways.

The Ripple Effect of Mutations

Interestingly, even neighboring normal endothelial cells can be affected by those with mutations. The mutant cells can emit signals that influence their non-mutated neighbors, leading to further growth and complexity in the vascular structure. It’s like having a rowdy group of friends that inadvertently drags everyone else into their wild antics!

Challenges in Treatment

The treatment landscape for vascular malformations is far from straightforward. Because VMs can be so variable and affect different individuals in unique ways, doctors must tailor therapies for each case. Sometimes the standard treatments simply don’t work, leading to frustration for patients and healthcare providers alike.

Future Directions

Research is ongoing to better understand how VMs develop and how to improve treatments. Scientists are exploring various biochemical and mechanical pathways to find new ways to tackle these malformations. The ultimate goal is to develop effective therapies that can help those affected without the need for invasive procedures.

The Takeaway

Vascular malformations represent a complex challenge in medicine. They stem from genetic changes that affect the normal formation and function of blood vessels. By understanding these processes better, researchers hope to improve diagnosis and treatment options for those suffering from these conditions.

And who knows, maybe one day, with further research and innovation, we'll have the tools to tackle these vascular villains effectively! But until then, staying informed and understanding how they work is crucial. After all, knowledge is power, even when it comes to twisted blood vessels!

Original Source

Title: Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations

Abstract: Somatic activating mutations in PIK3CA are common drivers of vascular and lymphatic malformations. Despite common biophysical signatures of tissues susceptible to lesion formation, including compliant extracellular matrix and low rates of perfusion, lesions vary in clinical presentation from localized cystic dilatation to diffuse and infiltrative vascular dysplasia. The mechanisms driving the differences in disease severity and variability in clinical presentation and the role of the biophysical microenvironment in potentiating progression are poorly understood. Here, we investigate the role of hemodynamic forces and the biophysical microenvironment in the pathophysiology of vascular malformations, and we identify hemodynamic shear stress and defective endothelial cell mechanotransduction as key regulators of lesion progression. We found that constitutive PI3K activation impaired flow-mediated endothelial cell alignment and barrier function. We show that defective shear stress sensing in PIK3CAE542Kendothelial cells is associated with reduced myosin light chain phosphorylation, junctional instability, and defective recruitment of vinculin to cell-cell junctions. Using 3D microfluidic models of the vasculature, we demonstrate that PIK3CAE542Kmicrovessels apply reduced traction forces and are unaffected by flow interruption. We further found that draining transmural flow resulted in increased sprouting and invasion responses in PIK3CAE542K microvessels. Mechanistically, constitutive PI3K activation decreased cellular and nuclear elasticity resulting in defective cellular tensional homeostasis in endothelial cells which may underlie vascular dilation, tissue hyperplasia, and hypersprouting in PIK3CA-driven venous and lymphatic malformations. Together, these results suggest that defective nuclear mechanics, impaired cellular mechanotransduction, and maladaptive hemodynamic responses contribute to the development and progression of PIK3CA-driven vascular malformations.

Authors: Wen Yih Aw, Aanya Sawhney, Mitesh Rathod, Chloe P. Whitworth, Elizabeth L. Doherty, Ethan Madden, Jingming Lu, Kaden Westphal, Ryan Stack, William J. Polacheck

Last Update: 2024-12-09 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.08.22.609165

Source PDF: https://www.biorxiv.org/content/10.1101/2024.08.22.609165.full.pdf

Licence: https://creativecommons.org/licenses/by-nc/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles